The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This stock page is the Follow view. The Build view lets your agent query Ernexa Therapeutics Inc. owners, fund changes, insider filings, and source links through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ERNA"
Use Arkolith to show who owns Ernexa Therapeutics Inc., which funds added or reduced it, and which SEC filings prove each claim.
Not held in any tracked 13F filing yet.
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Feb 10, 2026 | Cherington Charles | 10% Owner | Buy (P) | 4.0M | $2.0M |
| Feb 10, 2026 | Cherington Charles | 10% Owner | Buy (P) | 4.0M | — |
| Jun 21, 2025 | Gurrola Sandra M | Sr. VP of Finance | Option exercise (M) | 30 | — |
| Jun 21, 2025 | Gurrola Sandra M | Sr. VP of Finance | Option exercise (M) | 30 | $0 |
| Jun 9, 2025 | Cherington Charles | 10% Owner | Buy (P) | 21.2M | $2.1M |
| Apr 2, 2025 | Cherington Charles | 10% Owner | Buy (P) | 3.8M | $377K |
| Feb 7, 2025 | Luther Sanjeev | President & CEO, Director | Grant (A) | 1.1M | $0 |
| Feb 7, 2025 | Cicala Peter | Director | Grant (A) | 51K | $0 |
| Feb 7, 2025 | Bristol James Arthur | Director | Grant (A) | 72K | $0 |
| Feb 7, 2025 | Gurrola Sandra M | Sr. VP of Finance | Grant (A) | 150K | $0 |
| Feb 7, 2025 | Wexler William A. | Director | Grant (A) | 125K | $0 |
| Jan 13, 2025 | Ratner Elena | Director | Grant (A) | 140K | $0 |
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ERNA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.